Related Organization(s)

You just read:

Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases

News provided by

Skyhawk Therapeutics

May 06, 2019, 09:19 ET